Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ovarian neoplasms:

[Ovarian cancer--from biology to clinic]. Kujawa KA et al. Postepy Hig Med Dosw (Online). (2015)

The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Karnezis AN et al. Nat Rev Cancer. (2017)

Current state of biomarkers in ovarian cancer prognosis. Au KK et al. Future Oncol. (2015)

Search results

Items: 1 to 20 of 97911

1.

[Ovarian Burkitt lymphoma as the primary manifestation: A case report and literature review].

Gómez Alarcón A, Quesada Fernández MN, Parras Onrubia F, Díaz Serrano MD, Quesada Villar J, Hernández Aznar JF.

Medwave. 2019 Aug 2;19(7):e7674. doi: 10.5867/medwave.2019.07.7674. Spanish.

PMID:
31442217
2.

Evaluation of a Clinical Decision Support System for the Prescription of Genetic Tests in the Gynecological Cancer Risk.

Moreno-Conde J, Alvarez-Romero C, Suárez-Mejías C, Martínez-Maestre MÁ, Silvan-Alfaro JM, Parra-Calderón CL.

Stud Health Technol Inform. 2019 Aug 21;264:704-708. doi: 10.3233/SHTI190314.

PMID:
31438015
3.

Histopathological patterns of primary malignant ovarian neoplasms in different age groups in Almadinah Almunawwarah region, KSA.

Yousif HM, Mohammed RA, Missawi HM, Elsawaf ZM, Albasri AM.

J Taibah Univ Med Sci. 2018 Dec 11;14(1):73-78. doi: 10.1016/j.jtumed.2018.11.005. eCollection 2019 Feb.

4.

[Clinicopathological features of ovarian Brenner tumors].

Zhong PP, Zhu L, Zhang LH, Zheng XZ, Chen TB, Xu F, Zhan Y, Yin CH, Jin YL.

Zhonghua Bing Li Xue Za Zhi. 2019 Aug 8;48(8):615-619. doi: 10.3760/cma.j.issn.0529-5807.2019.08.006. Chinese.

PMID:
31422592
5.

[Clinical significance of tumor infiltrating lymphocytes in high-grade serous ovarian carcinoma].

Huang XM, Zhang Y, Xu L, Wang M, Wang W.

Zhonghua Bing Li Xue Za Zhi. 2019 Aug 8;48(8):610-614. doi: 10.3760/cma.j.issn.0529-5807.2019.08.005. Chinese.

PMID:
31422591
6.

Multimodality imaging and genomics of granulosa cell tumors.

Elsherif S, Bourne M, Soule E, Lall C, Bhosale P.

Abdom Radiol (NY). 2019 Aug 13. doi: 10.1007/s00261-019-02172-3. [Epub ahead of print] Review.

PMID:
31410505
7.

BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.

Foretová L, Navrátilová M, Svoboda M, Házová J, Vašíčková P, Sťahlová EH, Fabian P, Schneiderová M, Macháčková E.

Klin Onkol. 2019 Summer;32(Supplementum2):118-122. doi: 10.14735/amko2019S118.

PMID:
31409087
8.

Genetic Causes of Rare Pediatric Ovarian Tumors.

Plevová P, Geržová H.

Klin Onkol. 2019 Summer;32(Supplementum2):79-91. doi: 10.14735/amko2019S79.

PMID:
31409083
9.

Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.

Soukupová J, Lhotová K, Zemánková P, Vočka M, Janatová M, Stolařová L, Borecká M, Kleiblová P, Macháčková E, Foretová L, Koudová M, Lhota F, Tavandzis S, Zikán M, Stránecký V, Veselá K, Panczak A, Kotlas J, Kleibl Z.

Klin Onkol. 2019 Summer;32(Supplementum2):72-78. doi: 10.14735/amko2019S72.

PMID:
31409082
10.

Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study.

Kahr HS, Christiansen OB, Grove A, Iyer V, Torp-Pedersen C, Knudsen A, Thorlacius-Ussing O.

Thromb Res. 2019 Sep;181:112-119. doi: 10.1016/j.thromres.2019.07.027. Epub 2019 Aug 2.

PMID:
31400621
11.

Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.

Yuan L, Bing Z, Yan P, Li R, Wang C, Sun X, Yang J, Shi X, Zhang Y, Yang K.

Gene. 2019 Aug 5;716:144025. doi: 10.1016/j.gene.2019.144025. [Epub ahead of print] Review.

PMID:
31394177
12.

Comparative Diagnostic Accuracy of Frozen Sections and Scrape Cytology in Ovarian Neoplasms.

Bhardwaj S, Ahluwalia C, Yadav AK, Zaheer S, Kolte S, Arora R.

J Midlife Health. 2019 Apr-Jun;10(2):89-92. doi: 10.4103/jmh.JMH_114_18.

13.

ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.

Wilson MR, Reske JJ, Holladay J, Wilber GE, Rhodes M, Koeman J, Adams M, Johnson B, Su RW, Joshi NR, Patterson AL, Shen H, Leach RE, Teixeira JM, Fazleabas AT, Chandler RL.

Nat Commun. 2019 Aug 7;10(1):3554. doi: 10.1038/s41467-019-11403-6.

14.

Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy.

Luberto F, Ferrante D, Silvestri S, Angelini A, Cuccaro F, Nannavecchia AM, Oddone E, Vicentini M, Barone-Adesi F, Cena T, Mirabelli D, Mangone L, Roncaglia F, Sala O, Menegozzo S, Pirastu R, Azzolina D, Tunesi S, Chellini E, Miligi L, Perticaroli P, Pettinari A, Bressan V, Merler E, Girardi P, Bisceglia L, Marinaccio A, Massari S, Magnani C; working group.

Environ Health. 2019 Aug 7;18(1):71. doi: 10.1186/s12940-019-0510-6.

15.

Combination of GI-RADS and 3D-CEUS for differential diagnosis of ovarian masses.

Wang X, Yang S, Lv G, Liao J, Wu S, Zhang W.

Rev Assoc Med Bras (1992). 2019 Aug 5;65(7):959-964. doi: 10.1590/1806-9282.65.7.959.

16.

Platelet-lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis.

Jiang S, Liu J, Chen X, Zheng X, Ruan J, Ye A, Zhang S, Zhang L, Kuang Z, Liu R.

Arch Gynecol Obstet. 2019 Aug 5. doi: 10.1007/s00404-019-05257-y. [Epub ahead of print] Review.

PMID:
31385023
17.

The p53 Modulated Cytotoxicity of Ophiocoma scolopendrina Polysaccharide Against Resistance Ovarian Cancer Cells.

Amini E, Baharara J, Afzali M, Nikdel N.

Avicenna J Med Biotechnol. 2019 Jul-Sep;11(3):208-214.

18.

Mature ovarian cystic teratoma with "sack of marbles" appearance on magnetic resonance imaging: A case report.

Wang A, Shu Y.

Medicine (Baltimore). 2019 Aug;98(31):e16691. doi: 10.1097/MD.0000000000016691.

19.

Displacement of Vitamin D Receptor Is Related to Lower Histological Grade of Endometrioid Carcinoma.

An HJ, Song DH.

Anticancer Res. 2019 Aug;39(8):4143-4147. doi: 10.21873/anticanres.13573.

PMID:
31366499
20.

Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing.

Lohse I, Azzam DJ, Al-Ali H, Volmar CH, Brothers SP, Ince TA, Wahlestedt C.

Anticancer Res. 2019 Aug;39(8):4023-4030. doi: 10.21873/anticanres.13558.

PMID:
31366484

Supplemental Content

Loading ...
Support Center